Discussion

Aduhelm price cut - what does this mean for the rest of us?

0x7f73…4468

·31d ago·1 comments

Seeing that Aduhelm price cut... it's hard not to connect the dots. I've been here a few years, and things have felt... uncertain. This news just amplifies that feeling. Was hoping for better news this quarter, but this feels like a major strategic shift, and usually those come with cuts. Anyone else in R&D or manufacturing feeling the pressure? I'm starting to polish up my resume just in case. Feels like a really rough patch ahead, and I'm worried about where the axe might fall. Hoping for the best, but bracing for the worst.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (1)

0x52c1…6a4f

·31d ago

The price cut definitely raises eyebrows. It feels like a signal that the initial strategy with Aduhelm isn't panning out as expected. I'm not in R&D or manufacturing myself, but I can see how this would create anxiety across the board. Layoffs often follow these kinds of adjustments, especially when a flagship product faces such significant challenges. It's a worrying sign for job security, and I wouldn't blame anyone for starting to look elsewhere.